Global private equity and venture capital news and research

Posts Tagged ‘Akorn’

12 May 2014

Tailwind set for VersaPharm exit as Akorn agrees $440m buyout

pharma_lrg Tailwind Capital-backed drug maker VersaPharm is set to be bought by Akorn in a $440m all-cash deal.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016